Product Catalog


> LCN2 / NGAL Protein & Antibody LCN2 / NGAL Protein & Antibody
Lipocalin 2 (Neutrophil Gelatinase-Associated Lipocalin)
LCN2 / NGAL Products
LCN2 / NGAL Protein, Recombinant
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| LCN2/NGAL | Human | LCN2/NGAL Protein, Recombinant![]() |
10222-H08H |
| LCN2/NGAL | Mouse | LCN2/NGAL Protein, Recombinant![]() |
50060-M08H |
| LCN2/NGAL | Rat | LCN2/NGAL Protein, Recombinant![]() |
80058-R08B |
LCN2 / NGAL Antibody
| Molecule | Application | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| Human LCN2/NGAL |
WB, ELISA | LCN2/NGAL Antibody, Rabbit PAb | 10222-RP01 |
| Human LCN2/NGAL |
WB, ELISA | LCN2/NGAL Antibody, Rabbit Pab (Antigen Affinity Purified) | 10222-RP02 |
| Human LCN2/NGAL |
WB, ELISA | LCN2 / NGAL Antibody | 10222-R128 |
| Human LCN2/NGAL |
ELISA | LCN2 / NGAL Antibody | 10222-R210 |
| Mouse LCN2/NGAL |
WB, ELISA | Rabbit Polyclonal Antibody | 50060-RP01 |
| Mouse LCN2/NGAL |
WB, ELISA | Rabbit Polyclonal Antibody (Antigen Affinity Purified) | 50060-RP02 |
| Mouse LCN2/NGAL |
WB, ELISA | LCN2 / NGAL Antibody | 50060-R211 |
| Rat LCN2/NGAL |
WB, ELISA | LCN2 / NGAL Antibody | 80058-RP01 |
LCN2 / NGAL cDNA Clone
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| LCN2/NGAL | Human | Homo sapiens LCN2/NGAL cDNA Clone(NM_005564.3) | HG10222-M |
| LCN2/NGAL | Mouse | Mus musculus LCN2/NGAL cDNA Clone | MG50060-M |
| LCN2/NGAL | Mouse | Mouse LCN2 / NGAL ORF Expression Clone, untagged | MG50060-M-N |
| LCN2/NGAL | Rat | Rat LCN2/NGAL cDNA Clone / ORF Clone | RG80058-M |
LCN2 / NGAL Related Areas
Enzyme>>Protease & Regulator>>Metalloprotease & Regulator>>LCN2/NGAL
LCN2 / NGAL Alternative Names
LCN2, NGAL, MSFI, 24p3 [Homo sapiens]
Lcn2, 24p3, RP23-161B9.11, AW212229, Sip24 [Mus musculus]
LCN2 / NGAL Background
Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), is a 25 kDa protein belonging to the lipocalin superfamily. It was initially found in activated neutrophils, however, many other cells, like kidney tubular cells, may produce NGAL in response to various insults. This protein is released from injured tubular cells after various damaging stimuli, is already known by nephrologists as one of the most promising biomarkers of incoming Acute Kidney Injury (AKI). Recent evidence also suggests its role as a biomarker in a variety of other renal and non-renal conditions. Moreover, recent studies seem to suggest a potential involvement of this factor also in the genesis and progression of chronic kidney diseases. NGAL is the first known mammalian protein which specifically binds organic molecules called siderophores, which are high-affinity iron chelators. NGAL, first known as an antibacterial factor of natural immunity, and an acute phase protein, is currently one of the most interesting and enigmatic proteins involved in the process of tumor development. acting as an intracellular iron carrier and protecting MMP9 from proteolytic degradation, NGAL has a clear pro-tumoral effect, as has already been observed in different tumors (e.g. breast, stomach, oesophagus, brain) in humans. In thyroid carcinomas, NGAL is strongly induced by NF-kB, an important factor involved both in tumor growth and in the link between chronic inflammation and neoplastic development. Thus, Lipocalin-2 (LCN2/NGAL) has been implicated in a variety of processes including cell differentiation, proliferation, survival and morphogenesis.
LCN2 / NGAL Related Studies
- Schmidt-Ott KM, et al. (2006) Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens. 15(4): 442-9.
- Bolignano D, et al. (2010) Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett. 288(1): 10-6.
- Soni SS, et al. (2010) NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol. 42(1): 141-50.
- Bolignano D, et al. (2010) From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology. Eur J Clin Invest. 40(3): 273-6.
LCN2 (NGAL) related areas, pathways, and other information

+86-400-890-9989


